Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way-Reference-Cited by-同舟云学术

Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way

Published:2017-09-14 Issue:6 Volume:112 Page:
ISSN:0300-8428
Container-title:Basic Research in Cardiology
language:en
Short-container-title:Basic Res Cardiol

Author:

Schlüter Klaus-Dieter^ORCID,Wolf Annemarie,Weber Martin,Schreckenberg Rolf,Schulz Rainer

Funder

Sanofi

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Link

http://link.springer.com/article/10.1007/s00395-017-0650-1/fulltext.html

Reference36 articles.

1. Barriga M, Cal R, Cabello N, Llach A, Vallmitjana A, Benitez R, Badimon L, Cinca J, Llorentes-Cortes V, Hove-Madsen L (2013) Low density lipoproteins promote unstable calcium handling accompanied by reduced SERCA2 and connexin-40 expression in cardiomyocytes. PLoS One 8:e15828. doi: 10.1371/journal.pone.0058128

2. Chandrakala AN, Sukul D, Selvarajan K, Sai-Sudhakar C, Sun B, Parthasarathy S (2012) Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance of ischemic heart failure. Am J Physiol Cell Physiol 302:C165–C177. doi: 10.1152/ajpcell/00116.2011

3. Ding Z, Liu S, Wang X, Deng X, Fan Y, Shahanawaz J, Shmookler Reis RJ, Varughese KI, Sawamura T, Mehta JL (2015) Cross-talk between LOX-1 and PCSK9 in vascular tissue. Cardiovasc Res 107:556–567. doi: 10.1093/cvr/cvv178

4. Euler G (2016) Mechanisms of cardiac cell death. In: Schlüter K-D (ed) Cardiomyocytes—active players in cardiac disease. Springer, Berlin, pp 247–266. doi: 10.1007/978-3-319-31251-4_9

5. Fearon IM (2006) OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production. Cardiovasc Res 69:855–864. doi: 10.1016/j.cardiores.2005.11.019

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review);International Journal of Molecular Medicine;2024-05-10

2. Proteome-wide mendelian randomization investigates potential associations in heart failure and its etiology: emphasis on PCSK9;BMC Medical Genomics;2024-02-21

3. Maternal Obesity Modulates Cord Blood Concentrations of Proprotein Convertase Subtilisin/Kexin-type 9 Levels;Journal of the Endocrine Society;2024-02-19

4. PCSK9 regulates myofibroblast transformation through the JAK2/STAT3 pathway to regulate fibrosis after myocardial infarction;Biochemical Pharmacology;2024-02

5. Inhibition of PCSK9 enhances the anti-hepatocellular carcinoma effects of TCR-T cells and anti-PD-1 immunotherapy;International Journal of Biological Sciences;2024